Biomerica (NASDAQ: BMRA) CEO adds 31,250 shares in private placement
Rhea-AI Filing Summary
BIOMERICA INC (BMRA) reported an insider share purchase by Chief Executive Officer and director Zackary S. Irani. On August 26, 2026, he purchased 31,250 shares of Biomerica common stock at $1.60 per share in a private placement conducted by Biomerica.
The transaction was made pursuant to a Securities Purchase Agreement dated August 20, 2026 involving certain institutional and individual investors, including B. Riley Principal Capital, LLC and certain members of Biomerica’s board and executive officers. Following this transaction, Irani directly holds 242,570 common shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 31,250 shares
Net Buy
1 txn
Insider
Irani Zackary S.
Role
Chief Executive Officer
Bought
31,250 shs ($50K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common stock F1 | 31,250 | $1.60 | $50K |
Holdings After Transaction:
Common stock — 242,570 shares (Direct)
Footnotes (1)
- F1. On August 26, 2026, the reporting person acquired 31,250 shares of the Issuer's common stock at a purchase price of $1.60 per share in private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated August 20, 2026, by and among certain institutional and individual investors identified on the signature pages thereto, which included among others B. Riley Principal Capital, LLC and certain members of the Company's Board of Directors and executive officers.
Key Figures
Shares purchased: 31,250 shares of common stock
Purchase price per share: $1.60 per share
Shares owned after transaction: 242,570 shares of common stock
+2 more
5 metrics
Shares purchased
31,250 shares of common stock
Purchased on August 26, 2026 in a private placement
Purchase price per share
$1.60 per share
Price for the 31,250 shares acquired on August 26, 2026
Shares owned after transaction
242,570 shares of common stock
Direct holdings of Zackary S. Irani following the purchase
Transaction date
August 26, 2026
Date the private placement purchase was completed
Securities Purchase Agreement date
August 20, 2026
Agreement governing the private placement
Key Terms
private placement, Securities Purchase Agreement, institutional investors, Beneficial ownership
4 terms
private placement financial
"acquired 31,250 shares ... at a purchase price of $1.60 per share in private placement by the Issuer"
A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.
Securities Purchase Agreement financial
"pursuant to the terms of a Securities Purchase Agreement dated August 20, 2026"
A securities purchase agreement is a written contract between a buyer and a seller outlining the terms for buying or selling financial assets such as stocks or bonds. It specifies details like the price, quantity, and conditions of the transaction, similar to a shopping list with agreed-upon terms. For investors, it provides clarity and legal protection when transferring ownership of these financial instruments.
institutional investors financial
"by and among certain institutional and individual investors identified on the signature pages"
Institutional investors are large organizations, like pension funds, insurance companies, and mutual funds, that invest huge amounts of money on behalf of many people. Their decisions can influence the economy because they buy and sell big chunks of stocks, bonds, or other assets. They matter because their actions can affect market prices and trends.
Beneficial ownership financial
"the reporting person acquired 31,250 shares of the Issuer's common stock"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
FAQ
What insider transaction did BMRA report for Zackary S. Irani?
Biomerica reported that CEO and director Zackary S. Irani purchased 31,250 shares of common stock on August 26, 2026 at $1.60 per share in a private placement by the company under a Securities Purchase Agreement dated August 20, 2026.
Was the BMRA insider transaction part of a private placement?
Yes. The filing states that on August 26, 2026, 31,250 shares of Biomerica common stock were acquired at $1.60 per share in a private placement by the issuer under a Securities Purchase Agreement dated August 20, 2026.
Who participated with the BMRA CEO in the August 2026 private placement?
The Securities Purchase Agreement dated August 20, 2026 covered certain institutional and individual investors, including B. Riley Principal Capital, LLC and certain members of Biomerica’s Board of Directors and executive officers, in addition to CEO Zackary S. Irani.
AI-generated analysis. How Rhea-AI works. Not financial advice.
